519 related articles for article (PubMed ID: 26334052)
21. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.
Meyers K; Rodriguez K; Moeller RW; Gratch I; Markowitz M; Halkitis PN
PLoS One; 2014; 9(12):e114700. PubMed ID: 25502768
[TBL] [Abstract][Full Text] [Related]
22. Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons.
Pattacini L; Murnane PM; Baeten JM; Fluharty TR; Thomas KK; Bukusi E; Katabira E; Mugo N; Donnell D; Lingappa JR; Celum C; Marzinke M; McElrath MJ; Lund JM;
J Infect Dis; 2015 Jun; 211(12):1943-52. PubMed ID: 25520426
[TBL] [Abstract][Full Text] [Related]
23. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic prevention of human immunodeficiency virus in women: practical approaches for the obstetrician and gynecologist.
Hong JN; Farel CE; Rahangdale L
Obstet Gynecol Surv; 2015 Apr; 70(4):284-90. PubMed ID: 25900528
[TBL] [Abstract][Full Text] [Related]
25. Statistical issues in trials of preexposure prophylaxis.
Dunn DT; Glidden DV
Curr Opin HIV AIDS; 2016 Jan; 11(1):116-21. PubMed ID: 26545264
[TBL] [Abstract][Full Text] [Related]
26. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
Jain S; Krakower DS; Mayer KH
Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
[TBL] [Abstract][Full Text] [Related]
27. Editorial Commentary: Keeping Our Eyes on the Prize: No New HIV Infections With Increased Use of HIV Pre-exposure Prophylaxis.
Koester KA; Grant RM
Clin Infect Dis; 2015 Nov; 61(10):1604-5. PubMed ID: 26334051
[No Abstract] [Full Text] [Related]
28. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
[TBL] [Abstract][Full Text] [Related]
29. A cost-effectiveness analysis of HIV preexposure prophylaxis for men who have sex with men in Australia.
Schneider K; Gray RT; Wilson DP
Clin Infect Dis; 2014 Apr; 58(7):1027-34. PubMed ID: 24385445
[TBL] [Abstract][Full Text] [Related]
30. What do Dutch MSM think of preexposure prophylaxis to prevent HIV-infection? A cross-sectional study.
Bil JP; Davidovich U; van der Veldt WM; Prins M; de Vries HJ; Sonder GJ; Stolte IG
AIDS; 2015 May; 29(8):955-64. PubMed ID: 25915169
[TBL] [Abstract][Full Text] [Related]
31. Patient Disengagement From an HIV Preexposure Prophylaxis Program in a Sexually Transmitted Disease Clinic.
Dombrowski JC; Golden MR; Barbee LA; Khosropour CM
Sex Transm Dis; 2018 Sep; 45(9):e62-e64. PubMed ID: 29485544
[TBL] [Abstract][Full Text] [Related]
32. Preexposure Prophylaxis (PrEP) for HIV Prevention: The Primary Care Perspective.
Conniff J; Evensen A
J Am Board Fam Med; 2016; 29(1):143-51. PubMed ID: 26769887
[TBL] [Abstract][Full Text] [Related]
33. The role of healthcare providers in the roll out of preexposure prophylaxis.
Krakower DS; Mayer KH
Curr Opin HIV AIDS; 2016 Jan; 11(1):41-8. PubMed ID: 26417953
[TBL] [Abstract][Full Text] [Related]
34. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
Sagaon-Teyssier L; Suzan-Monti M; Demoulin B; Capitant C; Lorente N; Préau M; Mora M; Rojas Castro D; Chidiac C; Chas J; Meyer L; Molina JM; Spire B;
AIDS Care; 2016; 28 Suppl 1(sup1):48-55. PubMed ID: 26883400
[TBL] [Abstract][Full Text] [Related]
35. A Clinical Home for Preexposure Prophylaxis: Diverse Health Care Providers' Perspectives on the "Purview Paradox".
Hoffman S; Guidry JA; Collier KL; Mantell JE; Boccher-Lattimore D; Kaighobadi F; Sandfort TG
J Int Assoc Provid AIDS Care; 2016; 15(1):59-65. PubMed ID: 26293904
[TBL] [Abstract][Full Text] [Related]
36. Transitioning to HIV Pre-Exposure Prophylaxis (PrEP) from Non-Occupational Post-Exposure Prophylaxis (nPEP) in a Comprehensive HIV Prevention Clinic: A Prospective Cohort Study.
Siemieniuk RA; Sivachandran N; Murphy P; Sharp A; Walach C; Placido T; Bogoch II
AIDS Patient Care STDS; 2015 Aug; 29(8):431-6. PubMed ID: 26154174
[TBL] [Abstract][Full Text] [Related]
37. Prescription of Preexposure Prophylaxis to Men Who Have Sex With Men Diagnosed and Reported With Gonorrhea, STD Surveillance Network, 2016.
Ramirez V; Han E; Stoltey J; Nguyen TQ; Pathela P; Tourdot L; Walters J; Bell T; Torrone E; Stenger M
Sex Transm Dis; 2018 Aug; 45(8):e57-e60. PubMed ID: 29465634
[TBL] [Abstract][Full Text] [Related]
38. Low willingness and actual uptake of pre-exposure prophylaxis for HIV-1 prevention among men who have sex with men in Shanghai, China.
Ding Y; Yan H; Ning Z; Cai X; Yang Y; Pan R; Zhou Y; Zheng H; Gao M; Rou K; Wu Z; He N
Biosci Trends; 2016 May; 10(2):113-9. PubMed ID: 27052151
[TBL] [Abstract][Full Text] [Related]
39. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
Haberer JE
Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
[TBL] [Abstract][Full Text] [Related]
40. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.
Shaeer KM; Sherman EM; Shafiq S; Hardigan P
J Am Pharm Assoc (2003); 2014; 54(6):610-7. PubMed ID: 25343624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
